Apple stock continues to show relative strength ahead of its upcoming earnings report amid a sell-off in semiconductor stocks.
Why HNGE Stock advanced +1.41% Today — RQD Quant Desk Flash
Hinge Health Inc. (HNGE) carries a Roarable Rating of C (Hold) with 64/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
Why HNGE Stock advanced +1.41% Today — RQD Quant Desk Flash
Hinge Health Inc. (HNGE) advanced +1.41% to $116.90 as options desks priced 57% call premium vs. 43% put protection around the $115 max-pain magnet. Solid 80% profit margin (-35% return on capital), mixed timing at current multiples—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 99% of its 52-week range ($30.08 – $117.55) with RSI-14 at 67.5 (BULLISH MOMENTUM).
- ▸Whale Options Positioning: $2.6M in bullish call flow vs. $1.9M in put flow (Put/Call 0.75x, implied earnings swing ±7.7%).
- ▸Fundamental Anchor: Roarable C (Hold) backed by 79.6% gross margin and $170.7M annual free cash flow.
HNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support its growth prospects despite investment pressures.
Hinge Health’s fair value estimate has shifted from US$110.56 to US$114.31, signaling a modest adjustment in the price target baked into current models. Recent analyst research links these changes to a mix of higher targ
Investing.com -- Bank of America analysts highlighted three application software stocks they expect to deliver strong third-quarter results, emphasizing that selectivity has become critical in the sector as artificial in
Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live HNGE Tape Review)
- ✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
- ✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
- ✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen
HNGE Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +50.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on HNGE today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for HNGE. Explore sector supply chains on /butterfly.
HNGE Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is HNGE stock moving today?
Why HNGE Stock advanced +1.41% Today — RQD Quant Desk Flash. Solid 80% profit margin (-35% return on capital), mixed timing at current multiples—hold if owned, no rush to chase.